144 related articles for article (PubMed ID: 25295936)
1. Thymocyte transformation enhanced.
Pouliot GP; Gutierrez A
Nat Med; 2014 Oct; 20(10):1096-7. PubMed ID: 25295936
[No Abstract] [Full Text] [Related]
2. A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia.
Herranz D; Ambesi-Impiombato A; Palomero T; Schnell SA; Belver L; Wendorff AA; Xu L; Castillo-Martin M; Llobet-Navás D; Cordon-Cardo C; Clappier E; Soulier J; Ferrando AA
Nat Med; 2014 Oct; 20(10):1130-7. PubMed ID: 25194570
[TBL] [Abstract][Full Text] [Related]
3. An oncogenic enhancer enemy (N-Me) in T-ALL.
Herranz D; Ferrando AA
Cell Cycle; 2015; 14(2):167-8. PubMed ID: 25584678
[No Abstract] [Full Text] [Related]
4. T-ALL pathogenesis requires a NOTCH1-driven MYC enhancer.
Cancer Discov; 2014 Nov; 4(11):OF17. PubMed ID: 25367958
[TBL] [Abstract][Full Text] [Related]
5. The NOTCH1-MYC highway toward T-cell acute lymphoblastic leukemia.
Sanchez-Martin M; Ferrando A
Blood; 2017 Mar; 129(9):1124-1133. PubMed ID: 28115368
[TBL] [Abstract][Full Text] [Related]
6. Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.
Rakowski LA; Garagiola DD; Li CM; Decker M; Caruso S; Jones M; Kuick R; Cierpicki T; Maillard I; Chiang MY
Cancer Res; 2013 Jan; 73(2):930-41. PubMed ID: 23161489
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of EZH2, NOTCH1, IL7R, and PHF6 Mutations in Adult T-cell Acute Lymphoblastic Leukemia.
Zhou X; Gu Y; Han Q; Soliman M; Song C; Ge Z
Turk J Haematol; 2017 Dec; 34(4):366-368. PubMed ID: 28747286
[No Abstract] [Full Text] [Related]
8. Occurrence of identical NOTCH1 mutation in non-twinned sisters with T-cell acute lymphoblastic leukemia.
Mansur MB; Ford AM; van Delft FW; Gonzalez D; Emerenciano M; Maia RC; Greaves M; Pombo-de-Oliveira MS
Leukemia; 2011 Aug; 25(8):1368-70. PubMed ID: 21556011
[No Abstract] [Full Text] [Related]
9. Complexity of NOTCH1 juxtamembrane insertion mutations in T-cell acute lymphoblastic leukemia.
Colomer-Lahiguera S; Strehl S
Leuk Lymphoma; 2016 May; 57(5):1219-22. PubMed ID: 26292904
[No Abstract] [Full Text] [Related]
10. Oncogenesis of T-ALL and nonmalignant consequences of overexpressing intracellular NOTCH1.
Li X; Gounari F; Protopopov A; Khazaie K; von Boehmer H
J Exp Med; 2008 Nov; 205(12):2851-61. PubMed ID: 18981238
[TBL] [Abstract][Full Text] [Related]
11. Interconnecting molecular pathways in the pathogenesis and drug sensitivity of T-cell acute lymphoblastic leukemia.
Sanda T; Li X; Gutierrez A; Ahn Y; Neuberg DS; O'Neil J; Strack PR; Winter CG; Winter SS; Larson RS; von Boehmer H; Look AT
Blood; 2010 Mar; 115(9):1735-45. PubMed ID: 20007543
[TBL] [Abstract][Full Text] [Related]
12. Friend or foe: can activating mutations in NOTCH1 contribute to a favorable treatment outcome in patients with T-ALL?
Goldshtein A; Berger M
Crit Rev Oncog; 2014; 19(5):399-404. PubMed ID: 25404153
[TBL] [Abstract][Full Text] [Related]
13. How to resist Notch-targeted T-leukemia therapy: Lineage- and MYC enhancer switch.
Bayer M; Grosschedl R
Mol Cell; 2022 Mar; 82(5):884-886. PubMed ID: 35245453
[TBL] [Abstract][Full Text] [Related]
14. T-cell lymphoblastic leukemia in early childhood presents NOTCH1 mutations and MLL rearrangements.
Mansur MB; Emerenciano M; Splendore A; Brewer L; Hassan R; Pombo-de-Oliveira MS;
Leuk Res; 2010 Apr; 34(4):483-6. PubMed ID: 19631984
[TBL] [Abstract][Full Text] [Related]
15. The frequency of NOTCH1 variants in T-acute lymphoblastic leukemia/lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma among Jordanian patients.
Abualhaj NZ; Dardas Z; Azab B; Ali D; Sughayer MA; Aladily TN; Ahram M
Ann Diagn Pathol; 2019 Apr; 39():53-58. PubMed ID: 30718223
[TBL] [Abstract][Full Text] [Related]
16. High selective pressure for Notch1 mutations that induce Myc in T-cell acute lymphoblastic leukemia.
Chiang MY; Wang Q; Gormley AC; Stein SJ; Xu L; Shestova O; Aster JC; Pear WS
Blood; 2016 Nov; 128(18):2229-2240. PubMed ID: 27670423
[TBL] [Abstract][Full Text] [Related]
17. Tcf1 is essential for initiation of oncogenic Notch1-driven chromatin topology in T-ALL.
Antoszewski M; Fournier N; Ruiz Buendía GA; Lourenco J; Liu Y; Sugrue T; Dubey C; Nkosi M; Pritchard CEJ; Huijbers IJ; Segat GC; Alonso-Moreno S; Serracanta E; Belver L; Ferrando AA; Ciriello G; Weng AP; Koch U; Radtke F
Blood; 2022 Apr; 139(16):2483-2498. PubMed ID: 35020836
[TBL] [Abstract][Full Text] [Related]
18. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
[TBL] [Abstract][Full Text] [Related]
19. A novel TRB@/NOTCH1 fusion gene in T-cell lymphoblastic lymphoma with t(7;9)(q34;q34).
Yamamoto K; Nakamachi Y; Yakushijin K; Miyata Y; Okamura A; Kawano S; Matsuoka H; Minami H
Eur J Haematol; 2013 Jan; 90(1):68-75. PubMed ID: 23033986
[TBL] [Abstract][Full Text] [Related]
20. A Tumor Suppressor Enhancer of
Tottone L; Lancho O; Loh JW; Singh A; Kimura S; Roels J; Kuchmiy A; Strubbe S; Lawlor MA; da Silva-Diz V; Luo S; Gachet S; García-Prieto CA; Hagelaar R; Esteller M; Meijerink JPP; Soulier J; Taghon T; Van Vlierberghe P; Mullighan CG; Khiabanian H; Rocha PP; Herranz D
Blood Cancer Discov; 2021 Jan; 2(1):92-109. PubMed ID: 33458694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]